Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Carlos Alvarez MorenoDaibeth Henriquez

Abstract

To perform active targeted prospective surveillance to measure device-associated infection (DAI) rates, attributable mortality due to DAI, and the microbiological and antibiotic resistance profiles of infecting pathogens at 10 intensive care units (ICUs) in 9 hospitals in Colombia, all of which are members of the International Infection Control Consortium. We conducted prospective surveillance of healthcare-associated infection in 9 hospitals by using the definitions of the US Centers for Disease Control and Prevention National Nosocomial Surveillance System (NNIS). DAI rates were calculated as the number of infections per 100 ICU patients and per 1,000 device-days. During the 3-year study, 2,172 patients hospitalized in an ICU for an aggregate duration of 14,603 days acquired 266 DAIs, for an overall DAI rate of 12.2%, or 18.2 DAIs per 1,000 patient-days. Central venous catheter (CVC)-related bloodstream infection (BSI) (47.4% of DAIs; 11.3 cases per 1,000 catheter-days) was the most common DAI, followed by ventilator-associated pneumonia (VAP) (32.3% of DAIs; 10.0 cases per 1,000 ventilator-days) and catheter-associated urinary tract infection (CAUTI) (20.3% of DAIs; 4.3 cases per 1,000 catheter-days). Overall, 65.4% of all S...Continue Reading

References

Jun 9, 1977·The New England Journal of Medicine·D G MakiH W Sarafin
Jun 1, 1991·The Journal of Hospital Infection·R Freeman
Feb 1, 1991·American Journal of Infection Control·T G EmoriR P Gaynes
Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Oct 5, 1994·JAMA : the Journal of the American Medical Association·S Lemeshow, J R Le Gall
May 25, 1994·JAMA : the Journal of the American Medical Association·D PittetR P Wenzel
Sep 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E BergR A Weinstein
Feb 1, 1996·American Journal of Respiratory and Critical Care Medicine·D PittetP M Suter
Mar 20, 1996·JAMA : the Journal of the American Medical Association·J Y FagonC Gibert
Dec 31, 1997·The Pediatric Infectious Disease Journal·L K ArchibaldW R Jarvis
Jan 23, 1998·American Journal of Infection Control·E VelascoV M Gonçalves
Sep 12, 1998·Annals of Internal Medicine·D J CookC Brun-Buisson
Nov 20, 1998·The Journal of Hospital Infection·I KurlatE Alvarez
Sep 3, 1999·American Journal of Respiratory and Critical Care Medicine·B DigiovineM Higgins
Sep 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·S HarbarthD Pittet
Nov 28, 2001·Current Infectious Disease Reports·Nasia SafdarDennis G. Maki
Mar 1, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Paul A TambyahDennis G Maki
May 11, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Giovanni Battista OrsiNorman Noah
Dec 4, 2002·American Journal of Infection Control·Naomi P O'gradyUNKNOWN Healthcare Infection Control Practices Advisory Committee
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·C A AriasUNKNOWN Columbian Antimicrobial Resistance Group (RESCOL)
Apr 1, 2003·American Journal of Infection Control·Victor Daniel RosenthalPablo W Orellano
Jul 31, 2003·American Journal of Infection Control·Victor Daniel RosenthalPablo Wenceslao Orellano
Aug 16, 2003·The Journal of Hospital Infection·C S ReedD Spelman
Feb 6, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Victor Daniel RosenthalNasia Safdar
May 22, 2004·American Journal of Infection Control·Victor D Rosenthal, Dennis G Maki
Jul 9, 2004·Current Opinion in Infectious Diseases·Stéphane HugonnetDidier Pittet
Feb 24, 2006·American Journal of Infection Control·Victor D RosenthalChristopher Crnich

❮ Previous
Next ❯

Citations

May 7, 2013·Best Practice & Research. Clinical Obstetrics & Gynaecology·Hadiza Shehu Galadanci
Mar 1, 2012·Surgical Infections·Therèse M DuaneRao R Ivatury
Oct 18, 2012·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Sanjeev SinghPrem Nair
Jun 3, 2009·Critical Care Medicine·Ilias I SiemposApostolos E Armaganidis
May 19, 2012·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Victor D RosenthalUNKNOWN International Nosocomial Infection Control Members
Feb 4, 2010·Annals of Clinical Microbiology and Antimicrobials·Manuel S Rangel-FraustoVictor D Rosenthal
Oct 23, 2010·Indian Journal of Medical Microbiology·S SinghS Trivedi
Jan 10, 2008·Annals of Cardiac Anaesthesia·Mandakini PawarVictor Daniel Rosenthal
Oct 7, 2008·American Journal of Infection Control·Victor D RosenthalUNKNOWN International Nosocomial Infection Control Consortium Members
Aug 26, 2014·The Lancet. Respiratory Medicine·Jordi RelloDespoina Koulenti
Jul 7, 2011·Infection·V D RosenthalUNKNOWN International Nosocomial Infection Control Consortium members
Feb 24, 2016·Interdisciplinary Perspectives on Infectious Diseases·Sachin C Deorukhkar, Santosh Saini
Sep 13, 2011·American Journal of Infection Control·Victor D RosenthalUNKNOWN INICC members
Aug 16, 2011·Medicina intensiva·M J López, J A Cortés
Dec 15, 2010·Lancet·Victor D Rosenthal
Oct 4, 2008·Best Practice & Research. Clinical Anaesthesiology·Walter ZinggBernhard Walder
Mar 25, 2008·Journal of Critical Care·John G MuscedereDaren K Heyland
Feb 24, 2010·American Journal of Infection Control·Victor D RosenthalUNKNOWN INICC Members
Mar 8, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ashish BhargavaKeith S Kaye
Oct 30, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Victor D RosenthalUNKNOWN International Nosocomial Infection Control Consortium Investigators
Aug 28, 2014·Critical Reviews in Microbiology·Jaime A LabarcaManuel Guzmán-Blanco
Jun 25, 2015·Antimicrobial Resistance and Infection Control·Moi Lin LingLai Chee Lee
May 27, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Yaseen ArabiAntonio Anzueto
Aug 19, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Lili TaoLixian He
Jun 10, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·E GirãoS F Costa
Apr 1, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·H Guanche-GarcellD Fernández-González
Sep 3, 2014·American Journal of Infection Control·Víctor Daniel RosenthalUNKNOWN International Nosocomial Infection Control Consortium
Feb 8, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Victor Daniel RosenthalMaría Corazon V Tolentino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.